Plasma therapy clinical trial to begin in Kolkata

Clinical trial of convalescent plasma therapy is all set to begin in Kolkata with the Drug Control General of India giving its final nod to a collaborative effort by the Council of Scientific & Industrial Research (CSIR) and the Bengal government. The purpose of the trial is to study the efficacy of blood plasma from a recovered Covid-19 patient on a positive patient undergoing treatment. To begin with, willing plasma donors will be screened to select those eligible for donation.

from https://ift.tt/2TcKa7D
via IFTTT